Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik® ...Middle East

Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal's footprint in the United States. With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol). Since 2017, Grünenthal has invested more than €2 billion in...

Hence then, the article about grunenthal acquires us company valinor pharma and becomes global owner of movantik was published today ( Monday 22/07/2024 - 01:44 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik® )

Also on site :

• Führend in einer neuen Ära der Familienmobilität! CHERY TIGGO V, das 3-in-1-Familienfahrzeug, debütiert auf der AutoChina2026
• NYT ‘Connections’ Hints, Clues and Answers Monday, April 27, 2026
• King Charles US visit: What to know about the itinerary, Congress address